Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
55 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
Rank Status Study
1 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
2 Not yet recruiting Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial
Condition: Spondylitis, Ankylosing
Intervention: Behavioral: Brief Intervention
3 Recruiting Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
Condition: Ankylosing Spondylitis
Intervention:
4 Unknown  Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab
5 Not yet recruiting COMorbidities and EDucation in SPondyloArthritis Study
Condition: Axial Spondyloarthritis
Interventions: Behavioral: self-assessment/self-management;   Behavioral: Comorbidities (detection/prevention)
6 Unknown  Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
Condition: Moderate to Severe Active Axial Spondyloarthritis
Interventions: Drug: Etanercept 25mg;   Drug: Sulfasalazine
7 Recruiting Progression of Spinal Fusion in Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
8 Unknown  European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Condition: Ankylosing Spondylitis
Intervention:
9 Not yet recruiting Phase 3, Multicenter, Doubleblind, Rand Dalbavancin vs Comparator in Ped Acute Hematogenous Osteomyelitis
Condition: Osteomyelitis
Interventions: Drug: Dalbavancin;   Drug: cefazolin, nafcillin, oxacillin or vancomycin
10 Recruiting Safety and Efficacy Study of Daptomycin When Compared to Active Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis
Condition: Acute Hematogenous Osteomyelitis
Interventions: Drug: Daptomycin;   Drug: Vancomycin;   Drug: nafcillin
11 Recruiting Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for the Treatment of Diabetic Foot Osteomyelitis
Condition: Osteomyelitis
Interventions: Drug: piperacillin/tazobactam, cefepime, metronidazole, aztreonam,vancomycin, daptomycin, linezolid ,meropenem;   Drug: sulfamethoxazole/trimethoprim , clindamycin ,linezolid, moxifloxacin ,ciprofloxacin ,metronidazole
12 Recruiting 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
Condition: Spondylitis, Ankylosing
Interventions: Drug: Secukinumab;   Drug: Placebo secukinumab
13 Not yet recruiting Physical Training Program in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Personalized physical training program
14 Recruiting Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Condition: Ankylosing Spondylitis
Intervention:
15 Not yet recruiting An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
Condition: Spondylitis, Ankylosing
Interventions: Drug: Infliximab;   Drug: NSAIDs;   Drug: DMARDs
16 Recruiting Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients
Condition: Ankylosing Spondylitis
Intervention:
17 Recruiting A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life
Condition: Axial Spondyloarthritis
Intervention:
18 Recruiting Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Conditions: Hematogenously Acquired Stapylococcus Aureus Osteomyelitis;   Bone Infection;   Osteomyelitis
Intervention: Drug: Ceftaroline Fosamil
19 Not yet recruiting Patients Response to Early Switch To Oral:Osteomyelitis Study
Condition: Osteomyelitis
Interventions: Drug: oral antibiotics;   Procedure: intravenous antibiotics
20 Recruiting Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Tofacitinib 2 mg;   Drug: Tofacitinib 5 mg;   Drug: Tofacitinib 10 mg;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years